Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Philip, Cooney"'
Autor:
Philip Cooney, Arthur White
Publikováno v:
Medical Decision Making. 43:325-336
Background In decision modeling with time-to-event data, there are a variety of parametric models that can be used to extrapolate the survival function. Each model implies a different hazard function, and in situations in which there is moderate cens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92cafca46d81f52d5e238cbabcc3c6c8
https://doi.org/10.1177/0272989x221150212
https://doi.org/10.1177/0272989x221150212
Autor:
Moogeh, Baharnoori, Virender, Bhan, Fraser, Clift, Kimberly, Thomas, Soukaïna, Mouallif, Nicholas, Adlard, Philip, Cooney, François, Blanchette, Barkha P, Patel, Daniel, Grima
Publikováno v:
PharmacoEconomics - Open. 6:859-870
Ofatumumab is a high-efficacy disease-modifying therapy (DMT) approved for first-line treatment of relapsing-remitting multiple sclerosis (RRMS) in Canada.The aim of this study was to evaluate the cost effectiveness of ofatumumab from a Canadian heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f44d876d250f6588064ef41c5c472f8
https://doi.org/10.1007/s41669-022-00363-1
https://doi.org/10.1007/s41669-022-00363-1
Publikováno v:
Journal of Diabetes & Metabolic Disorders. 21:1619-1624
Purpose Community pharmacists are highly accessible healthcare providers and studies in several countries have demonstrated a role for community pharmacists in delivering enhanced care to people with type 2 diabetes. The aim of this study is to evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d950313a9e176a3542acab0b9775495e
https://doi.org/10.1007/s40200-022-01111-2
https://doi.org/10.1007/s40200-022-01111-2
Autor:
Shelby Sydnor, Swarnendu Chatterjee, Philip Cooney, Simarjeet Kaur, Tom Macmillan, Daisy Stewart, Isobel Munro, Cátia Bandeiras, Abby Paine, Federico Felizzi
Publikováno v:
Diabetes Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11391d748698db830b709440cccaa7e5
https://doi.org/10.1007/s13300-023-01410-8
https://doi.org/10.1007/s13300-023-01410-8
Autor:
Philip Cooney, Farooq H. Maniyar, Pamela Vo, Umakanth Vudumula, Andriy Danyliv, Sreelatha Vadapalle, Jasper Huels, Peter J. Goadsby, Ronan Mahon, Andrea Lang
Publikováno v:
PharmacoEconomics. 39:357-372
Migraine is a common neurological disease that disproportionately affects females and has a peak incidence during productive years, resulting in significant burden. The aim of the study was to determine the cost effectiveness of erenumab for the prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b36be83033ffa466675dc06040c5b2be
https://doi.org/10.1007/s40273-020-00996-2
https://doi.org/10.1007/s40273-020-00996-2
Autor:
Andriy Danyliv, Pamela Vo, Peter J. Goadsby, Ronan Mahon, Philip Cooney, Victoria Hacking, Farooq H. Maniyar, Umakanth Vudumula, Jasper Huels, Stephen Palmer, Sreelatha Vadapalle
Publikováno v:
Journal of medical economics. 23(8)
Background: For novel migraine therapies, economic evaluations will be required to understand the trade-offs between additional health benefit and additional cost. The purpose of this study was to conduct a systematic literature review (SLR) to ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35db4a78fd4a9e27b2400c7506cd03e1
https://pubmed.ncbi.nlm.nih.gov/32285724
https://pubmed.ncbi.nlm.nih.gov/32285724